Lupus & antiphospholipid syndrome

Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study

Lupus Sci MedPublished Observational cohort study

Authors' conclusion

The outcome of inflammatory NPSLE after immunosuppressive treatment is generally good, with improvement of neuropsychiatric symptoms occuring in approximately 70% of events.

Study context

Population
Patients with SLE at the Leiden University Medical Centre neuropsychiatric SLE (NPSLE) clinic, 2007–2021, receiving immunosuppressive therapy for neuropsychiatric symptoms101 NPSLE events
Participants
95 patients
Outcome
Outcome of NP symptoms scored on a 7-point Likert scale (death to resolved) by two independent readers
Follow-up
Short-term (0-6 months) and long-term (7-24 months)
Methodological detailssingle-centre, tertiary referral centre, multidisciplinary consensus
  • Single-centre
  • Tertiary referral centre
  • Multidisciplinary consensus

Main finding

As reported in the abstract

Short-term outcome of NP symptoms (Likert scale) · 0-6 months
Improvement
73%
Improved
22%
Much improved
29%
Resolved
22%
No change
21%
Worsening
6%

Observational data: associations, not effects.

Further findings

Long-term outcome of NP symptoms (Likert scale) · 7-24 months

Improvement
70%
Improved
14%
Much improved
28%
Resolved
28%
No change
17%
Worsening
10%
Death
3%
  • Available for 78 out of 101 events

Most common NP manifestation: cognitive dysfunction

Cognitive dysfunction
50%

Treatment modalities

Induction
24%
Induction and maintenance
73%
Other therapy
3%
Prednisone
97%
Methylprednisolone
53%
AZA
49%
CYC
42%

Death (long-term) · 7-24 months

Death
3%
  • None directly NPSLE-related

Original publication

Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study. Lupus Sci Med. Published 3 February 2023. doi:10.1136/lupus-2022-000850

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.